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OCT-Based Diagnosis and Management of
STEMI Associated With Intact Fibrous Cap
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In autopsy studies, at least 25% of thrombotic coronary occlusions are caused by plaque erosion in which
thrombus often overlies atherosclerotic plaque without evident disruption of the fibrous cap. We per-
formed optical coherence tomography imaging after aspiration thrombectomy and identified plaque
erosion as the cause in 31 patients presenting with ST-segment elevation myocardial infarction. Plaque
erosion was identified when the fibrous cap of the culprit lesion was intact. Based on clinical criteria, 40%
of patients with subcritically occlusive plaque were treated with dual antiplatelet therapy without percu-
taneous revascularization (group 1), and the remaining 60% of patients underwent angioplasty and
stenting (group 2). At a median follow-up of 753 days, all patients were asymptomatic, regardless of stent
implantation. These observations support an alternative treatment strategy for patients with acute coro-
nary events and optical coherence tomography–verified intact fibrous cap (or plaque erosion), where
nonobstructive lesions might be managed without stenting. (J Am Coll Cardiol Img 2013;6:283–7)
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irmaOcclusive luminal thrombosis is the mecha-
nism underlying most acute coronary syn-
dromes (ACS). As many as 75% of autopsy
studies after fatal ACS relate thrombotic oc-
clusion to atherosclerotic plaque rupture; most
of the remainder involve plaque erosion. Less
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284and inflamed (Fig. 1). Discontinuity of the fibrous
cap brings circulating platelets into contact with the
highly thrombogenic plaque core, leading to acute
thrombus formation that occludes the arterial lu-
men. In contrast, erosion of plaque rich in pro-
teoglycans and smooth muscle cells predisposes to
thrombus formation over an intact fibrous cap
(IFC). Because the pathogenesis of ACS in patients
with an RFC differs from that in patients with an
IFC, it is possible that clinical management of these
2 groups of patients may differ.
See page 288
Current treatment guidelines for patients with
ACS rely heavily on catheter-based reperfusion of
the infarct-related artery and intracoronary stent
placement. The underlying plaque morphology is
not routinely identified because of the limited
resolution of conventional imaging modalities, such
as intravascular ultrasound. Because stenosis of the
arterial lumen might not always be signif-
icant in erosive pathology and the vessel
wall not disrupted, it seems reasonable
that reliable characterization of plaque
morphology might justify an alternative
approach that foregoes coronary stenting
as the initial strategy for this subset of
patients. Intracoronary optical coherence
tomography (OCT) provides superior res-
olution (10 to 15 m), allowing more
detailed analysis of plaque morphology
(2), including discriminating IFC from
FC in patients with ACS. Plaque rupture and
laque erosion in the culprit lesions of patients with
CS can be distinguished as discrete syndromes on
he basis of an RFC (ACS-RFC) and IFC (ACS-
FC) (2).
We describe a series of patients in whom ACS
as attributed to IFC after aspiration thrombec-
omy. A subset of these patients was treated with
ual antiplatelet therapy, without angioplasty or
tent placement. Considering the risks of in-stent
hrombosis and restenosis and the need for pro-
onged dual antiplatelet therapy that entails an
ncreased risk of bleeding, such an approach may
mprove long-term outcomes. From the OCT
atabases of 4 institutions, we identified 31
atients with ST-segment elevation myocardial
nfarction who underwent coronary angiography
ithin 12 h after the onset of symptoms with the
ntent to perform a primary percutaneous coronary
ntervention with thrombus aspiration. Patients pre- senting in cardiogenic shock were excluded. Proce-
ures were performed according to current clinical
ractice guidelines. The management decisions, in-
luding use of glycoprotein IIb/IIIa inhibitors or
ntiplatelet agents, and the decision to perform bal-
oon angioplasty or stent implantation were made by
he operator according to the local practice. Patients
eceived unfractionated heparin (5,000 to 10,000 IU),
spirin (300 mg before the primary percutaneous
oronary intervention, followed by 100 mg/day), and
lopidogrel (300 to 600 mg initially followed by 75
g/day) or prasugrel at the discretion of the treating
hysician (Table 1). After discharge, patients were
ollowed at 1 to 3 months and at 6 months, in
ccordance with local practice. One year after the
ndex ACS event, patients were evaluated again, either
n the clinic or by telephone by experienced research
urses.
Because thrombus hampers the assessment of un-
erlying plaque anatomy, erosion of the fibrous cap
as documented by OCT after the thrombus was
emoved or reduced by aspiration, as previously de-
cribed (2). Table 2 shows procedural and angio-
raphic characteristics of lesions in 12 patients in the
roup managed with thrombectomy only (group 1)
nd 19 cases in those managed with aspiration plus
tent implantation (group 2). Three patients in group
who were initially managed with systemic throm-
olysis at community hospitals and transferred did not
equire aspiration (Fig. 2). Sixty-seven percent of
atients in group 1 and 58% in group 2 presented with
otal coronary occlusions (Thrombolysis In Myocar-
ial Infarction [TIMI] flow grades 0 to 1; p  NS).
he median total ischemic times were 3.5 3.0 h and
.6 2.3 h in groups 1 and 2, respectively (p NS).
here was only mild residual stenosis and no differ-
nce between groups in the final TIMI flow grade
chieved (3 for each). After a median follow-up of 753
ays, target lesion revascularization was performed in
patient in group 2, but no myocardial infarction,
eart failure, or deaths occurred in either group.
Plaque erosion is an entity distinct from plaque
upture (1,2). Most erosive lesions are devoid of
ecrotic core, and, when present, the core does not
ommunicate with the lumen because of a thick
brous cap. Such lesions have been reported in
ounger individuals, including premenopausal
omen, with smoking as the most prevalent risk
actor. Many of these lesions display relatively minor
uminal narrowing, and thrombus removal without
alloon dilation or stent implantation may be suffi-
ient to restore vessel patency. The luminal thrombo-A B B R E V I A T I O N S
A N D A C R O N YM S
ACS acute coronary
syndromes
IFC intact fibrous cap
OCT optical coherence
tomography
RFC ruptured fibrous cap
TIMI Thrombolysis Inis in plaque erosion has been attributed to apoptosis
healed rupture site. The lesion is critically narrowed but does not show any po
intervention; RCA  right coronary artery.
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285or degradation of endothelial cells lining the plaque
surface. Therefore, after thrombus removal, treatment
with antiplatelet drugs may allow healing of the
endothelial layer. The mechanisms involved may be
similar to re-endothelialization after stent implanta-
tion. Avoiding stent deployment could potentially
que Rupture, and a Stable Plaque
ts with acute coronary syndromes (A,B) and a stable unrelated plaque
eas in the top panels are magniﬁed in the bottom panels for better
e. (A) The eroded plaque shows subcritical stenosis, an unremarkable
in smooth muscle cells and proteoglycans, and there is minimal inﬂam-
emodeling. (B) Conversely, a positively remodeled, critically occlusive
overed by a very thin and inﬂamed ﬁbrous cap, which is disrupted (area
al layer and thin ﬁbrous cap and minimally present at the base of the
essel lumen with an occlusive thrombus. (C) A stable plaque shows
the middle that separates the collagen of 2 separate ages represents a
sitive remodeling or overlying thrombus.
Table 2. Procedural Characteristics
Group 1
(n  12)
Group 2
(n  19) p Value
Glycoprotein IIb/IIIa
inhibitors
4 (33 4 (21) 0.73
ADP antagonists 0.042
Clopidogrel 7 (58) 18 (95)
Prasugrel 5 (42) 1 (5)
Angiographic analysis
Pre-aspiration DS, % 79.4 33.3 87.9 17.3 0.95
Post-aspiration DS, % 27.1 19.4 32.0 35.2 0.48
Pre-aspiration TIMI
ﬂow grade 2
9 (75) 15 (79) 0.85
Post-aspiration TIMI
ﬂow grade 2
1 (8) 0 0.81
Total ischemic time, h 3.5 3.0 3.6 2.3 0.82
Values are n (%) or mean  SD.
ADP  adenosine diphosphate; DS  diameter stenosis; TIMI  Thrombol-Figure 1. Histomorphological Characteristics of Plaque Erosion, Pla
Cross-sectional images of 2 culprit coronary plaques obtained from the patien
(C) from a nonculprit site in another patient with sudden death; the boxed ar
histological characterization. The sections are stained with Movat’s pentachrom
necrotic core, and overlying thrombus on an intact ﬁbrous cap. The cap is rich
mation at the base of the thrombus. The plaque does not show any positive r
atherosclerotic plaque with a cholesterol crystal–rich large necrotic core (NC) c
between the yellow arrowheads). Smooth muscle cells are visible in the medi
neointima. A large thrombogenic necrotic core is in communication with the v
smooth muscle and collagen-rich histology. The hemorrhagic necrotic core inTable 1. Patient Characteristics
Group 1
(n  12)
Group 2
(n  19) p Value
Male 10 (83) 16 (84)
Age, yrs 52.2 12.0 62.6 10.8 0.019
Diabetes 1 (8) 7 (37) 0.18
Dyslipidemia 4 (33) 8 (42) 0.94
Hypertension 1 (8) 10 (53) 0.033
Smoking 7 (58) 13 (68) 0.85
Family history 5 (42) 3 (16) 0.23
Previous MI 2 (17) 2 (10) 0.95
Previous PCI 1 (8) 2 (10) 0.67
LVEF % 54.5 13.2 53.8 14.2 0.55
MVD 2 (17) 6 (32) 0.61
Location of culprit lesion
LM 0 1 (5) 0.81
LAD 7 (58) 9 (47) 0.82
LCx 2 (17) 2 (10) 0.96
RCA 3 (25) 7 (37) 0.77
Values are n (%) or mean  SD.
LAD left anterior descending artery; LCx left circumﬂex artery; LM left
main coronary artery; LVEF  left ventricular ejection fraction; MI  myocar-
dial infarction; MVD  multivessel disease; PCI  percutaneous coronaryysis In Myocardial Infarction.
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286reduce the risks of both early (dissection, embolism,
occlusive thrombosis) and late (restenosis, neoathero-
sclerosis, and thrombosis) complications.
These observations suggest that characterization
of underlying plaque morphology by OCT may
Figure 2. Management of a Patient Presenting With Acute Coro
Severe chest discomfort and shortness of breath developed in a 66-ye
fort. He presented to a local hospital; his blood pressure was 96/57 mm
revealed ST-segment elevation in precordial leads (A). The coronary ris
emergent coronary angiography was performed 4 h after the onset of
left anterior descending coronary artery (A). Then intravenous adminis
was transferred to a tertiary cardiovascular care center for a percutane
onset of chest pain) demonstrated no thrombus or stenosis at the orig
scopy, and gray-scale intravascular ultrasound, and integrated backsca
was 399 (normal: 0.6 to 3.5) ng/ml, and troponin I was 60.80 (normal:
formation through the blue coronary angioscopy guide catheter, wher
protrusion mass with signal-free shadowing, but some signal reduction
images revealed an intact ﬁbrous cap (B). Intravascular ultrasound and
nantly a ﬁbrous plaque (green) and negligible lipid-rich component (b
nar reconstruction computed tomography images conﬁrmed the abse
original occlusion (D) and mainly normal coronary arteries.provide insight into the pathogenesis of some casesof ACS in which plaque erosion rather than rupture
is an underlying cause. Reliable identification of
these features may have practical implications for
management, allowing selection of patients who
can be treated using measures that reduce the
y Syndrome With an Intact Fibrous Cap
d man after 12 h of intermittent and stuttering retrosternal discom-
, his heart rate was 84 beats/min, and an electrocardiogram
tors included dyslipidemia and 46-pack-year smoking history. An
st pain, which revealed total occlusion of the proximal segment of
n of heparin (10,000 IU) and half-dose alteplase was started, and he
coronary intervention. Repeat coronary angiography (8 h after the
site of total occlusion. Optical coherence tomography (OCT), angio-
intravascular ultrasound (B, C) were performed. On arrival, CK-MB
to 0.06) ng/ml. Coronary angioscopy showed faint red thrombus
OCT did not show a typical red thrombus with a high backscattering
s observed from 12 to 3 o’clock positions (C). Multiple slices of OCT
grated backscatter intravascular ultrasound demonstrated predomi-
(C). No intervention was undertaken. Pre-discharge curved multipla-
of positive remodeling and no signiﬁcant stenosis at the site of thenar
ar-ol
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287coronary stenting. Because ACS-IFC appears to
involve a mechanism of luminal obstruction distinct
from that in ACS-RFC, a different interventional
approach to management may be warranted in these
cases. Perhaps the role of antithrombin agents may
warrant reconsideration in ACS-IFC. Further-
more, because these lesions involve an IFC, the risk
of intraplaque hemorrhage may be lower than in
those with ACS-RFC, raising the possibility that
specific strategies of catheter-directed lytic therapy
(e.g., plasmin) may be relatively safe and efficacious.
Definitive trials comparing the safety and efficacy of
these alternative approaches will depend foremost
on accurate imaging to exclude evidence of rupture
or calcification of the offending coronary lesion.
Study limitations. The limitations of this observa-
tional study include its nonrandomized design, small
sample size, and the lack of a comparison group of
ACS-RFC patients managed either with or without
stent implantation. Also, no conclusions can be drawn
about various alternative methods of thrombus re-
moval or adjunctive antithrombotic therapy, nor can
we be certain about the subclinical events occurring at
the plaque surface that promote thrombus formation
in patients with ACS-IFC and predispose to the onset1276–82.
2
2011;32:2814–23.Conclusions
We demonstrate in a limited number of patients
with ACS that characterization of plaque morphol-
ogy by OCT could identify nonobstructive lesions
amenable to treatment with an antiplatelet strategy
alone, without angioplasty or coronary stent deploy-
ment, and result in satisfactory clinical outcomes.
The PERADAM-OCT (Plaque Erosion in ACS:
OCT-Based Diagnosis And Management, An In-
ternational Registry) is beginning to gather addi-
tional data about the factors predisposing to plaque
erosion and clinical presentation on ACS in pa-
tients with lesions of this type. Randomized trials
will be needed, however, to clarify the role of
aspiration thrombectomy and catheter-directed
lytic therapy without stent implantation in cases of
OCT-verified ACS-IFC and further evaluate the
long-term outcomes of an alternative management
strategy for this unique cause of ACS.
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